LP
ALXN
LMR Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-524,772
| Closed | -$96.4M | – | 1340 |
|
|
2021
Q2 | $96.4M | Buy |
524,772
+42,747
| +9% | +$7.85M | 1.46% | 7 |
|
|
2021
Q1 | $73.7M | Buy |
482,025
+398,980
| +480% | +$61M | 1.84% | 4 |
|
|
2020
Q4 | $13M | Sell |
83,045
-77,140
| -48% | -$12.1M | 0.2% | 56 |
|
|
2020
Q3 | $18.3M | Buy |
160,185
+63,637
| +66% | +$7.28M | 0.38% | 33 |
|
|
2020
Q2 | $10.8M | Sell |
96,548
-26,230
| -21% | -$2.94M | 0.27% | 61 |
|
|
2020
Q1 | $10.7M | Buy |
+122,778
| New | +$10.7M | 0.5% | 53 |
|
|
2019
Q4 | – | Sell |
-64,978
| Closed | -$6.36M | – | 610 |
|
|
2019
Q3 | $6.36M | Buy |
64,978
+42,683
| +191% | +$4.18M | 0.31% | 53 |
|
|
2019
Q2 | $2.92M | Buy |
+22,295
| New | +$2.92M | 0.11% | 93 |
|
|
2017
Q3 | – | Sell |
-3,119
| Closed | -$379K | – | 618 |
|
|
2017
Q2 | $379K | Sell |
3,119
-4,525
| -59% | -$550K | 0.02% | 442 |
|
|
2017
Q1 | $927K | Buy |
+7,644
| New | +$927K | 0.09% | 134 |
|
|
2016
Q3 | – | Sell |
-17,417
| Closed | -$2.03M | – | 529 |
|
|
2016
Q2 | $2.03M | Buy |
+17,417
| New | +$2.03M | 0.32% | 96 |
|
|
2015
Q3 | – | Sell |
-7,629
| Closed | -$1.38M | – | 538 |
|
|
2015
Q2 | $1.38M | Buy |
7,629
+3,071
| +67% | +$555K | 0.17% | 175 |
|
|
2015
Q1 | $790K | Sell |
4,558
-1,309
| -22% | -$227K | 0.11% | 224 |
|
|
2014
Q4 | $1.09M | Buy |
+5,867
| New | +$1.09M | 0.14% | 194 |
|
|
2014
Q3 | – | Sell |
-21,179
| Closed | -$3.31M | – | 510 |
|
|
2014
Q2 | $3.31M | Buy |
+21,179
| New | +$3.31M | 0.28% | 94 |
|